Soru

Zorluk: KolayHematology and Oncology

A 68-year-old man with a history of atrial fibrillation is brought to the emergency department after vomiting large amounts of bright red blood. He takes warfarin daily. On presentation, he appears pale and lethargic. His temperature is 37.1°C (98.8°F), blood pressure is 88/56 mm Hg, and heart rate is 118/min. Physical examination reveals delayed capillary refill and cool extremities. Laboratory studies show a hemoglobin of 8.2 g/dL and an International Normalized Ratio (INR) of 8.4. Intravenous fluid resuscitation with normal saline is initiated. Which of the following is the most appropriate next step in management?

  1. A
    Administer intravenous vitamin K only
  2. B
    Administer protamine sulfate
  3. Administer prothrombin complex concentrate and intravenous vitamin KCevap
  4. D
    Administer fresh frozen plasma without vitamin K
  5. E
    Administer broad-spectrum intravenous antibiotics

Cevap

The most appropriate next step is to administer prothrombin complex concentrate and intravenous vitamin K.
Warfarin inhibits the enzyme vitamin K epoxide reductase, which prevents the activation of vitamin K-dependent clotting factors (II, VII, IX, and X). In the setting of severe, life-threatening bleeding with an elevated INR, immediate and sustained reversal of anticoagulation is mandatory. Prothrombin complex concentrate (PCC) contains concentrated factors II, VII, IX, and X, providing rapid correction of the coagulopathy with minimal volume load (unlike fresh frozen plasma). Intravenous vitamin K must be administered concurrently to provide the substrate needed for the liver to synthesize new endogenous clotting factors, which prevents rebound coagulopathy once the administered PCC degrades.

Adım Adım Çözüm

1
Identify the clinical emergency and patient stability.
The patient has severe, life-threatening gastrointestinal hemorrhage and is hemodynamically unstable (hypotensive and tachycardic).
Determines the urgency of intervention; conservative or slow-acting therapies are insufficient.
2
Determine the underlying etiology of the coagulopathy.
The patient is on warfarin and has a markedly supratherapeutic INR of 8.4.
Guides the choice of a specific pharmacologic reversal agent.
3
Select the optimal targeted therapy for rapid reversal.
Prothrombin complex concentrate (PCC) is selected for immediate factor replacement, combined with intravenous vitamin K for sustained effect.
PCC acts within minutes and has less volume load than fresh frozen plasma, making it the standard of care for severe warfarin-associated bleeding.

Anahtar Kavram

Severe, life-threatening bleeding associated with warfarin toxicity requires immediate reversal with prothrombin complex concentrate (PCC) and intravenous vitamin K.
Bu soruyu puanla